The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2053-2063

  Reddy, Aravind T ^a   Lakshmi, Sowmya P ^a   Dornadula, Sireesh ^a   Pinni, Sudheer ^a   Rampa, Dileep R ^a   Reddy, Raju C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 NITRO OLEIC ACID; ANTIINFLAMMATORY AGENT; FLUTICASONE PROPIONATE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG POTENCY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTRAPULMONARY DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; OLEIC ACIDS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84883382596     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300730     Document Type: Article

References (46)

1. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
2. Ying, S., G. Zhang, S. Gu, and J. Zhao. 2006. How much do we know about atopic asthma: where are we now? Cell. Mol. Immunol. 3: 321-332.
3. Adcock, I. M., and K. Ito. 2004. Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr. Opin. Pharmacol. 4: 257-262.
4. Barnes, P. J. 2006. Corticosteroids: the drugs to beat. Eur. J. Pharmacol. 533: 2-14.
5. Chanez, P., S. E. Wenzel, G. P. Anderson, J. M. Anto, E. H. Bel, L. P. Boulet, C. E. Brightling, W. W. Busse, M. Castro, B. Dahlen, et al. 2007. Severe asthma in adults: what are the important questions? J. Allergy Clin. Immunol. 119: 1337-1348.
6. Reddy, R. C. 2008. Severe asthma: approach and management. Postgrad. Med. J. 84: 115-120.
7. O'Donnell, V. B., J. P. Eiserich, A. Bloodsworth, P. H. Chumley, M. Kirk, S. Barnes, V. M. Darley-Usmar, and B. A. Freeman. 1999. Nitration of unsaturated fatty acids by nitric oxide-derived reactive species. Methods Enzymol. 301: 454-470.
8. Baker, P. R. S., F. J. Schopfer, S. Sweeney, and B. A. Freeman. 2004. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc. Natl. Acad. Sci. USA 101: 11577-11582.
9. Baker, P. R., Y. Lin, F. J. Schopfer, S. R. Woodcock, A. L. Groeger, C. Batthyany, S. Sweeney, M. H. Long, K. E. Iles, L. M. Baker, et al. 2005. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 280: 42464-42475.
10. Schopfer, F. J., Y. Lin, P. R. S. Baker, T. Cui, M. Garcia-Barrio, J. Zhang, K. Chen, Y. E. Chen, and B. A. Freeman. 2005. Nitrolinoleic acid: an endoge-nous peroxisome proliferator-activated receptor γ ligand. Proc. Natl. Acad. Sci. USA 102: 2340-2345.
11. Cui, T., F. J. Schopfer, J. Zhang, K. Chen, T. Ichikawa, P. R. Baker, C. Batthyany, B. K. Chacko, X. Feng, R. P. Patel, et al. 2006. Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281: 35686-35698.
12. Coles, B., A. Bloodsworth, S. R. Clark, M. J. Lewis, A. R. Cross, B. A. Freeman, and V. B. O'Donnell. 2002. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ. Res. 91: 375-381.
13. Kansanen, E., G. Bonacci, F. J. Schopfer, S. M. Kuosmanen, K. I. Tong, H. Leinonen, S. R. Woodcock, M. Yamamoto, C. Carlberg, S. Ylä-Herttuala, et al. 2011. Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism. J. Biol. Chem. 286: 14019-14027.
14. Reddy, A. T., S. P. Lakshmi, and R. C. Reddy. 2012. The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-Induced Acute Lung Injury in Mice. PPAR Res. 2012: 617063.
15. Borniquel, S., E. A. Jansson, M. P. Cole, B. A. Freeman, and J. O. Lundberg. 2010. Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease. Free Radic. Biol. Med. 48: 499-505.
16. Rudolph, V., T. K. Rudolph, F. J. Schopfer, G. Bonacci, S. R. Woodcock, M. P. Cole, P. R. Baker, R. Ramani, and B. A. Freeman. 2010. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc. Res. 85: 155-166.
17. Liu, H., Z. Jia, S. Soodvilai, G. Guan, M. H. Wang, Z. Dong, J. D. Symons, and T. Yang. 2008. Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury. Am. J. Physiol. Renal Physiol. 295: F942-F949.
18. Reddy, A. T., S. P. Lakshmi, and R. C. Reddy. 2012. Murine model of allergen induced asthma. J. Vis. Exp. (63): e3771.
19. Reddy, A. T., S. P. Lakshmi, J. M. Kleinhenz, R. L. Sutliff, C. M. Hart, and R. C. Reddy. 2012. Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury. J. Immunol. 189: 5411-5420.
20. Xu, L., X. W. Dong, L. L. Shen, F. F. Li, J. X. Jiang, R. Cao, H. Y. Yao, H. J. Shen, Y. Sun, and Q. M. Xie. 2012. Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. Int. Immunopharmacol. 12: 556-564.
21. Lakshmi, S. P., A. T. Reddy, M. U. Naik, U. P. Naik, and R. C. Reddy. 2012. Effects of JAM-A deficiency or blocking antibodies on neutrophil migration and lung injury in a murine model of ALI. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L758-L766.
22. Luo, Y., and M. E. Dorf. 2001. Isolation of mouse neutrophils. Curr. Protoc. Immunol. Chapter 3: Unit 3.20.
23. Barnes, P. J. 2006. Transcription factors in airway diseases. Lab. Invest. 86: 867-872.
24. Barnes, P. J., and I. M. Adcock. 2003. How do corticosteroids work in asthma? Ann. Intern. Med. 139: 359-370.
25. Pascual, G., A. L. Fong, S. Ogawa, A. Gamliel, A. C. Li, V. Perissi, D. W. Rose, T. M. Willson, M. G. Rosenfeld, and C. K. Glass. 2005. A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437: 759-763.
26. Li, M., G. Pascual, and C. K. Glass. 2000. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20: 4699-4707.
27. Chen, F., M. Wang, J. P. O'Connor, M. He, T. Tripathi, and L. E. Harrison. 2003. Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J. Cell. Biochem. 90: 732-744.
28. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18: 621-663.
29. Reddy, R. C., V. R. Narala, V. G. Keshamouni, J. E. Milam, M. W. Newstead, and T. J. Standiford. 2008. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-gamma. Blood 112: 4250-4258.
30. Majai, G., Z. Sarang, K. Csomós, G. Zahuczky, and L. Fésü s. 2007. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur. J. Immunol. 37: 1343-1354.
31. Bratton, D. L., and P. M. Henson. 2011. Neutrophil clearance: when the party is over, clean-up begins. Trends Immunol. 32: 350-357.
32. Birrell, M. A., H. J. Patel, K. McCluskie, S. Wong, T. Leonard, M. H. Yacoub, and M. G. Belvisi. 2004. PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. Eur. Respir. J. 24: 18-23.
33. Asada, K., S. Sasaki, T. Suda, K. Chida, and H. Nakamura. 2004. Antiinflammatory roles of peroxisome proliferator-activated receptor γ in human alveolar macrophages. Am. J. Respir. Crit. Care Med. 169: 195-200.
34. Reddy, R. C. 2008. Immunomodulatory role of PPAR-gamma in alveolar macrophages. J. Investig. Med. 56: 522-527.
35. Cox, G. 1995. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154: 4719-4725.
36. Sun, L., A. C. Nicholson, D. P. Hajjar, A. M. Gotto, Jr., and J. Han. 2003. Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. J. Lipid Res. 44: 1877-1886.
37. McCubbrey, A. L., J. Sonstein, T. M. Ames, C. M. Freeman, and J. L. Curtis. 2012. Glucocorticoids relieve collectin-driven suppression of apoptotic cell uptake in murine alveolar macrophages through downregulation of SIRPα. J. Immunol. 189: 112-119.
38. European Network for Understanding Mechanisms of Severe Asthma. 2003. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur. Respir. J. 22: 470-477.
39. Wenzel, S. E., S. J. Szefler, D. Y. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 156: 737-743.
40. Jatakanon, A., C. Uasuf, W. Maziak, S. Lim, K. F. Chung, and P. J. Barnes. 1999. Neutrophilic inflammation in severe persistent asthma. Am. J. Respir. Crit. Care Med. 160: 1532-1539.
41. ten Brinke, A., A. H. Zwinderman, P. J. Sterk, K. F. Rabe, and E. H. Bel. 2004. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am. J. Respir. Crit. Care Med. 170: 601-605.
42. Barnes, P. J., and M. Karin. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071.
43. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103-108.
44. Ji, C., K. R. Kozak, and L. J. Marnett. 2001. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem. 276: 18223-18228.
45. Musiek, E. S., J. D. Brooks, M. Joo, E. Brunoldi, A. Porta, G. Zanoni, G. Vidari, T. S. Blackwell, T. J. Montine, G. L. Milne, et al. 2008. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J. Biol. Chem. 283: 19927-19935.
46. Hou, Y., F. Moreau, and K. Chadee. 2012. PPARgamma is an E3 ligase that induces the degradation of NFkappaB/p65. Nat. Commun. 3: 1300.